Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of alpha-tocopherol: a synergistic interaction?
- PMID: 9733022
- DOI: 10.1080/10715769800300071
Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of alpha-tocopherol: a synergistic interaction?
Abstract
Oxidative damage has been implicated in the pathogenesis of inflammatory bowel diseases. 5-Aminosalicylic acid (5-ASA), the anti-inflammatory drug commonly used in the treatment of this condition, has been shown to possess antioxidant properties considered to be of particular importance in the pathologic context of these diseases. However, its action mechanisms are far from being completely elucidated, especially regarding its antioxidant properties in the presence of endogenous antioxidants such as alpha-tocopherol (alpha-T), the major defence system of biomembranes against lipid peroxidation. In this study we investigated the scavenging activity of 5-ASA toward peroxyl radicals generated at different sites of soybean PC liposomes, used as model membranes, either alone or in combination with alpha-T. 5-ASA, separately, shows strong scavenging activity toward peroxyl radicals generated in the aqueous phase by thermal decomposition of 2,2'-azobis(2-amidinopropane hydrochloride) (AAPH), inducing a clear concentration-dependent inhibition period, either of oxygen consumption or of conjugated diene hydroperoxides production. HPLC analysis indicates that 5-ASA is consumed, at a constant rate, throughout the reaction, and when the inhibition period is over, the oxidation rate is resumed. On the other hand, apart from a slight decrease in the rate of oxidation, 5-ASA is unable to suppress efficiently lipid peroxidation, when the reaction starts inside the lipid membranes, by thermal decomposition of 2,2'-azobis(2,4-dimethylvaleronitrile) (AMVN). When 5-ASA is combined with alpha-T, and the oxidation starts in the aqueous phase, an additive inhibitory effect occurs between both compounds. 5-ASA protects efficiently alpha-T against initial attack from AAPH-peroxyl radicals, delaying its consumption. On the other hand, if the reaction starts inside the lipid bilayer, 5-ASA prolongs significantly the inhibitory period produced by alpha-T on the initial rate of oxidation, as measured by oxygen consumption and conjugated diene hydroperoxides. This inhibitory effect points to a synergistic interaction between 5-ASA and alpha-T, since 5-ASA, by itself, is unable to suppress the oxidation reaction. Therefore, 5-ASA reveals an important cooperative effect with alpha-T, either affording an efficient protection to this antioxidant compound, when free radicals are generated in the aqueous site, or potentiating its activity when oxidation is initiated inside the lipid bilayer. Taking into account that the ascorbic acid content decreases significantly in the inflamed mucosa of patients with inflammatory bowel diseases, our data are, certainly, a very important contribution to the knowledge of the anti-inflammatory action of 5-ASA.
Similar articles
-
Reaction of melatonin with lipoperoxyl radicals in phospholipid bilayers.Free Radic Biol Med. 1997;23(5):706-11. doi: 10.1016/s0891-5849(97)00018-x. Free Radic Biol Med. 1997. PMID: 9296446
-
Antioxidant activity of all-trans-retinol in homogeneous solution and in phosphatidylcholine liposomes.Arch Biochem Biophys. 1993 Nov 15;307(1):217-23. doi: 10.1006/abbi.1993.1581. Arch Biochem Biophys. 1993. PMID: 8239660
-
Antioxidant activity of a novel vitamin E derivative, 2-(alpha-D glucopyranosyl)methyl-2,5,7,8-tetramethylchroman-6-ol.Free Radic Biol Med. 1998 Jan 15;24(2):217-25. doi: 10.1016/s0891-5849(97)00221-9. Free Radic Biol Med. 1998. PMID: 9433895
-
Vitamin E and its function in membranes.Prog Lipid Res. 1999 Jul;38(4):309-36. doi: 10.1016/s0163-7827(99)00008-9. Prog Lipid Res. 1999. PMID: 10793887 Review.
-
Mechanisms and dynamics of antioxidant action of ubiquinol.Mol Aspects Med. 1997;18 Suppl:S63-70. doi: 10.1016/s0098-2997(97)00035-6. Mol Aspects Med. 1997. PMID: 9266507 Review.
Cited by
-
Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study.World J Gastroenterol. 2005 Dec 7;11(45):7118-21. doi: 10.3748/wjg.v11.i45.7118. World J Gastroenterol. 2005. PMID: 16437657 Free PMC article. Clinical Trial.
-
5-Aminosalicylic acid protection against oxidative damage to synaptosomal membranes by alkoxyl radicals in vitro.Neurochem Res. 2001 Jan;26(1):23-9. doi: 10.1023/a:1007620330168. Neurochem Res. 2001. PMID: 11358278
-
Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy.Diseases. 2024 Aug 1;12(8):172. doi: 10.3390/diseases12080172. Diseases. 2024. PMID: 39195171 Free PMC article.
-
Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon.Int J Colorectal Dis. 2007 Sep;22(9):1103-8. doi: 10.1007/s00384-007-0299-6. Epub 2007 Mar 28. Int J Colorectal Dis. 2007. PMID: 17390144 Clinical Trial.
-
Comparison between 5-aminosalicylic acid (5-ASA) and para-aminosalicylic acid (4-PAS) as potential protectors against Mn-induced neurotoxicity.Biol Trace Elem Res. 2013 Apr;152(1):113-6. doi: 10.1007/s12011-012-9597-0. Epub 2013 Jan 15. Biol Trace Elem Res. 2013. PMID: 23315311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical